Condition
Antidepressant Drug Adverse Reaction
Total Trials
5
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown3
Recruiting2
Clinical Trials (5)
Showing 5 of 5 trials
NCT06763081Recruiting
Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation
NCT03953014Recruiting
Pharmacogenetics of Antidepressant-Induced Disinhibition
NCT05099913Not ApplicableUnknown
The Role of Neuromodulators in Refractory Functional Dyspepsia
NCT04830241Unknown
Neonatal Hypotonia Associated With in Utero Exposure to Antidepressant
NCT00817011Not ApplicableUnknown
Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness
Showing all 5 trials